Results 191 to 200 of about 282,352 (292)

To include or not include: renal dialysis policy in the era of universal health coverage.

BMJ, 2020
Teerawattananon Y, Dabak SV, Khoe LC, Bayani DBS, Isaranuwatchai W.   +4 more
europepmc   +1 more source

Predictors of late presentation to renal dialysis: a cohort study of linked primary and secondary care records in East London. [PDF]

BMJ Open, 2019
Olaitan A, Ashman N, Homer K, Hull S.
europepmc   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides

European Journal of Heart Failure, EarlyView.
Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima, Desirée Wussler, Pedro Lopez‐Ayala, Maria Belkin, Albina Nowak, Xueting Lin, Ivo Strebel, Fabiana Sgueglia, Eleni Michou, Androniki Papachristou, Laureve Chollet, Codruta Popescu, Nikola Kozhuharov, Samyut Shrestha, Gabriela Kuster, Katharina Rentsch, Arnold Von Eckardstein, Mascha Binder, Felix Mahfoud, Tobias Breidthardt, Christian Mueller   +20 more
wiley   +1 more source

Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)

European Journal of Heart Failure, EarlyView.
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz, Juel Maalouli Schaar, Katharina R. Welker, Lucas Lauder, Felix Götzinger, Ingrid Kindermann, Martin Schulz, Michael Böhm, Markus R. Meyer, Felix Mahfoud   +9 more
wiley   +1 more source

Rationale and design of the TRIC‐I‐HF‐DZHK24 (TRICuspid Intervention in Heart Failure) trial

European Journal of Heart Failure, EarlyView.
Study overview of the TRIC‐I‐HF‐DZHK24 trial. HF, heart failure; HFH, heart failure hospitalization; QoL, quality of life; RHC, right heart catheterization; TR, tricuspid regurgitation; TTVI, transcatheter tricuspid valve intervention. Abstract Aims Tricuspid regurgitation (TR) is a detrimental disease frequently diagnosed in patients with right‐sided ...
Thomas J. Stocker, Tobias Geisler, Wolfgang Rottbauer, Edith Lubos, Christian Frerker, Niklas Schofer, Johanne Frank, Ralph Stephan von Bardeleben, Tobias Kister, Rico Osteresch, Alexander Lauten, Tienush Rassaf, Jürgen Rothe, David M. Leistner, Lukas Stolz, Victoria Kehl, Maria Grzeschniok, Andreas Hagendorff, Volker Rudolph, Stephan Baldus, Philipp Lurz, Steffen Massberg, Jörg Hausleiter, for the TRIC‐I‐HF‐DZHK24 Investigators, Jörg Hausleiter, Thomas J. Stocker, Steffen Massberg, Lukas Stolz, Michael Näbauer, Ludwig Weckbach, Philipp Doldi, Julia Novotny, Tobias Geisler, Meinrad Gawaz, Andreas Goldschmidt, Monika Zdanyte, Wolfgang Rottbauer, Mirjam Keßler, Edith Lubos, Christian Frerker, Roza Saraei, Ingo Eitel, Tobias Schmidt, Thomas Stiermaier, Momir Dejanovikj, Sebastian Kupp, Mulham Alhagi, Niklas Schofer, Daniel Kalbacher, Johanne Frank, Derk Frank, Matthias Lutz, Mohammed Saad, Stephan von Bardeleben, Philipp Lurz, Tobias Ruf, Theresa Gößler, Volker Rudolph, Kai Peter Friedrichs, Tanja Rudolph, Maria Ivannikova, Werner Scholtz, Hazem Omran, Tobias Kister, Holger Thiele, Rico Osteresch, Rainer Hambrecht, Alexander Lauten, Tienush Rassaf, Amir A. Mahabadi, Jürgen Rothe, Christian Besler, Mirjam Wild, Dirk Westermann, Nikolaus Löffelhardt, Roman Pfister, Stephan Baldus, Christos Iliadis, Dennis Mehrkens, Erion Xhepa, Michael Joner, Teresa Trenkwalder, Hector A. Covarrubias, Friederike Schürmann, Heribert Schunkert, David Leistner, Amin Polzin, Malte Kelm, Patrick Horn, Ralf Westenfeld, Eike Tigges, Georg Nickenig, Marcel Weber, Margarita Schulz, Johanna Vogelhuber, Dominik Nelles, Christian Butter, Mathias Konstandin, Norbert Frey, Philipp Nikolai, Raffi Bekeredjian, Alexander Wolf, Marc M. Vorpahl, Ulf Landmesser, Markus Reinthaler Fabian Barbieri, Joachim Schofer, Christina Brinkmann, Bernhard Unsöld, Kerstin Piayda, Sven Möbius‐Winkler, Christian Schulze   +110 more
wiley   +1 more source

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies [PDF]

, 2008
Glorieux, Griet, Van Biesen, Wim, VAN LAECKE, STEVEN, Vanholder, Raymond, Verbeke, Francis   +4 more
core   +1 more source

Management of patients with heart failure at high risk of hyperkalaemia: The CARE‐HK in HF registry

European Journal of Heart Failure, EarlyView.
Primary results of the CARE‐HK in HF registry. ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; eGFR, estimated glomerular filtration rate; HF, heart failure; HK, hyperkalaemia; HR, hazard ratio; MRA, mineralocorticoid receptor antagonist; RASi,
Stephen J. Greene, Andrew J. Sauer, Michael Böhm, Biykem Bozkurt, Javed Butler, John G.F. Cleland, Andrew J.S. Coats, Nihar R. Desai, Diederick E. Grobbee, Ellie Kelepouris, Fausto Pinto, Giuseppe Rosano, Victoria Donachie, Solenn Fabien, Sandra Waechter, Maria G. Crespo‐Leiro, Martin Hülsmann, Tibor Kempf, Otmar Pfister, Anne‐Catherine Pouleur, Manish Saxena, Martin Schulz, Maurizio Volterrani, Stefan D. Anker, Mikhail N. Kosiborod   +24 more
wiley   +1 more source

The Policy Debate on Patient Care Financing for Victims of End-Stage Renal Disease [PDF]

, 1976
Rettig, Richard A.
core   +1 more source

Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Katja Rohwedder, Meike Brinker, Patrick Schloemer, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan   +15 more
wiley   +1 more source